Correlation Between Citigroup and BioAdaptives

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and BioAdaptives at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and BioAdaptives into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and BioAdaptives, you can compare the effects of market volatilities on Citigroup and BioAdaptives and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of BioAdaptives. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and BioAdaptives.

Diversification Opportunities for Citigroup and BioAdaptives

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Citigroup and BioAdaptives is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and BioAdaptives in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAdaptives and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with BioAdaptives. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAdaptives has no effect on the direction of Citigroup i.e., Citigroup and BioAdaptives go up and down completely randomly.

Pair Corralation between Citigroup and BioAdaptives

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.07 times more return on investment than BioAdaptives. However, Citigroup is 14.22 times less risky than BioAdaptives. It trades about 0.3 of its potential returns per unit of risk. BioAdaptives is currently generating about 0.0 per unit of risk. If you would invest  7,294  in Citigroup on May 22, 2025 and sell it today you would earn a total of  2,128  from holding Citigroup or generate 29.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Citigroup  vs.  BioAdaptives

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
BioAdaptives 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days BioAdaptives has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, BioAdaptives is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Citigroup and BioAdaptives Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and BioAdaptives

The main advantage of trading using opposite Citigroup and BioAdaptives positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, BioAdaptives can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAdaptives will offset losses from the drop in BioAdaptives' long position.
The idea behind Citigroup and BioAdaptives pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes